These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30874813)

  • 1. European Heart Journal - Cardiovascular Pharmacotherapy: now accepted for an official Impact Factor.
    Agewall S
    Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):59. PubMed ID: 30874813
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction and Vision.
    Birnbaum Y
    Cardiovasc Drugs Ther; 2020 Feb; 34(1):1-2. PubMed ID: 32034644
    [No Abstract]   [Full Text] [Related]  

  • 3. European Heart Journal - Cardiovascular Pharmacotherapy has received its first Impact Factor of 6.723.
    Agewall S
    Eur Heart J Cardiovasc Pharmacother; 2019 Oct; 5(4):183-184. PubMed ID: 31531677
    [No Abstract]   [Full Text] [Related]  

  • 4. Journal of Cardiovascular Pharmacology and Therapeutics: Expanding the Legacy.
    Przyklenk K
    J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):303. PubMed ID: 31170824
    [No Abstract]   [Full Text] [Related]  

  • 5. Seizing the Future: What's Next for the Journal of Cardiovascular Pharmacology?
    Booz GW
    J Cardiovasc Pharmacol; 2019 Jan; 73(1):1-2. PubMed ID: 30383608
    [No Abstract]   [Full Text] [Related]  

  • 6. A Thank You From the Editor-in-Chief.
    Kloner RA
    J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):90-91. PubMed ID: 30428713
    [No Abstract]   [Full Text] [Related]  

  • 7. European Heart Journal-Cardiovascular Pharmacotherapy to become fully open access in 2025.
    Agewall S
    Eur Heart J Cardiovasc Pharmacother; 2024 Aug; 10(5):370. PubMed ID: 39140999
    [No Abstract]   [Full Text] [Related]  

  • 8. The application to MEDLINE from European Heart Journal-Cardiovascular Pharmacotherapy has been accepted!
    Agewall S
    Eur Heart J Cardiovasc Pharmacother; 2016 Oct; 2(4):207-8. PubMed ID: 27600901
    [No Abstract]   [Full Text] [Related]  

  • 9. European Heart Journal-Cardiovascular Pharmacotherapy in 2016: entering a new level of international recognition.
    Atar D
    Eur Heart J Cardiovasc Pharmacother; 2017 Jan; 3(1):3-4. PubMed ID: 28062654
    [No Abstract]   [Full Text] [Related]  

  • 10. High impact Cardiovascular Research: beyond the heart and vessels.
    Small HY; Guzik TJ
    Cardiovasc Res; 2019 Dec; 115(14):e166-e171. PubMed ID: 31697316
    [No Abstract]   [Full Text] [Related]  

  • 11. New heights and hot topics in Cardiovascular Research.
    Small HY; Guzik TJ
    Cardiovasc Res; 2018 Dec; 114(14):e114-e119. PubMed ID: 30476014
    [No Abstract]   [Full Text] [Related]  

  • 12. PCVD 2020.
    Lavie CJ
    Prog Cardiovasc Dis; 2020; 63(1):74-75. PubMed ID: 31926995
    [No Abstract]   [Full Text] [Related]  

  • 13. What does the future hold for Cardiovascular Research?
    Sipido KR
    Cardiovasc Res; 2013 Jan; 97(1):1-3. PubMed ID: 23180721
    [No Abstract]   [Full Text] [Related]  

  • 14. State of the Journal: An Update.
    Marwick TH; Chandrashekhar Y
    JACC Cardiovasc Imaging; 2024 Aug; 17(8):1009-1011. PubMed ID: 39111990
    [No Abstract]   [Full Text] [Related]  

  • 15. Zoom-ing towards the Frontiers of science: a report on the first virtual session from Cardiovascular Research.
    Small HY; Cathcart B; Brown SK
    Cardiovasc Res; 2020 Jul; 116(8):e103-e105. PubMed ID: 32582930
    [No Abstract]   [Full Text] [Related]  

  • 16. [Editorial and scientific excellence of biomedical journals: Is the impact factor everything?].
    Alfonso F; Sanchís J
    Arch Cardiol Mex; 2015; 85(4):265-9. PubMed ID: 26521662
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact Factor and the Journal of Voice.
    Sataloff RT
    J Voice; 2019 Mar; 33(2):127-128. PubMed ID: 30798882
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial Board Position statement regarding the Declaration on Research Assessment (DORA) recommendations with respect to journal impact factors.
    Welk G; Fischman MG; Greenleaf C; Harrison L; Ransdell L; van der Mars H; Zhu W
    Res Q Exerc Sport; 2014 Dec; 85(4):429-30. PubMed ID: 25412123
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular pharmacotherapy-2015 was a good year.
    Lewis BS
    Eur Heart J Cardiovasc Pharmacother; 2016 Oct; 2(4):209-11. PubMed ID: 27600902
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of JIDC.
    Kelvin DJ; Wain J; Rubino S
    J Infect Dev Ctries; 2012 Jul; 6(7):542. PubMed ID: 22842939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.